Literature DB >> 25540973

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.

Umit Akyuz1, Atakan Yesil, Yusuf Yilmaz.   

Abstract

OBJECTIVE: Overweight and obesity are major risk factors for the development of nonalcoholic fatty liver disease (NAFLD). However, a minority of NAFLD patients have a body mass index (BMI) <25 kg/m(2) (lean NAFLD). We sought to investigate whether significant differences exist between lean NAFLD and more common forms of NAFLD associated with overweight/obesity. PATIENTS AND METHODS: A total of 483 consecutive patients with biopsy-proven NAFLD were enrolled. Lean NAFLD was defined as having a BMI <25 kg/m(2). We identified 37 patients with lean NAFLD (7.6%).
RESULTS: Compared with NAFLD patients with overweight/obesity, lean NAFLD patients were younger, had lower blood pressure values, higher levels of hemoglobin, a lower prevalence of the metabolic syndrome, and less severe hepatic fibrosis. In NAFLD patients with overweight/obesity, diabetes was the only independent predictor of nonalcoholic steatohepatitis (NASH). In lean NAFLD, the only variable independently associated with NASH was hemoglobin. Alanine aminotransferase and diabetes were independent predictors of fibrosis ≥2 in NAFLD patients with overweight/obesity, whereas hemoglobin was the only independent predictor of fibrosis ≥2 in lean NAFLD.
CONCLUSION: In summary, lean NAFLD patients are younger and show less severe hepatic fibrosis. However, such subjects have higher hemoglobin levels, which seem to predict the histological severity.

Entities:  

Keywords:  body mass index; fibrosis; hemoglobin; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Substances:

Year:  2014        PMID: 25540973     DOI: 10.3109/00365521.2014.983160

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  24 in total

1.  The metabolic profiles and body composition of lean metabolic associated fatty liver disease.

Authors:  Yu-Ming Cheng; Jia-Horng Kao; Chia-Chi Wang
Journal:  Hepatol Int       Date:  2021-02-04       Impact factor: 6.047

Review 2.  Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

Authors:  Eda Kaya; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

3.  Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.

Authors:  Yusuf Yılmaz; Haluk Tarık Kanı; Coşkun Özer Demirtaş; Eda Kaya; Aybüke Fatma Sapmaz; Lubna Qutranji; Tasnim Alkayyali; Kerim Deniz Batun; Mahmut Batman; Berk Toy; Aslı Çiftaslan
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

4.  Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis.

Authors:  Qianyi Wang; Hong You; Xiaojuan Ou; Xinyan Zhao; Yameng Sun; Min Wang; Ping Wang; Yu Wang; Weijia Duan; Xiaoming Wang; Shanshan Wu; Yuanyuan Kong; Romil Saxena; Annette S H Gouw; Jidong Jia
Journal:  Hepatol Int       Date:  2019-09-26       Impact factor: 6.047

Review 5.  Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.

Authors:  Eda Kaya; Yusuf Yilmaz
Journal:  J Clin Transl Hepatol       Date:  2021-10-19

Review 6.  Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.

Authors:  Ramesh Kumar; Shantam Mohan
Journal:  J Clin Transl Hepatol       Date:  2017-07-05

7.  Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.

Authors:  Philipp Bernhardt; Wolfgang Kratzer; Julian Schmidberger; Tilmann Graeter; Beate Gruener
Journal:  BMC Res Notes       Date:  2018-02-06

Review 8.  Lean NAFLD: an underrecognized and challenging disorder in medicine.

Authors:  Sheila Maier; Amanda Wieland; Melanie Cree-Green; Kristen Nadeau; Shelby Sullivan; Miguel A Lanaspa; Richard J Johnson; Thomas Jensen
Journal:  Rev Endocr Metab Disord       Date:  2021-01-03       Impact factor: 6.514

Review 9.  Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach.

Authors:  Natalia Nuño-Lámbarri; Varenka J Barbero-Becerra; Misael Uribe; Norberto C Chávez-Tapia
Journal:  Int J Mol Sci       Date:  2016-03-15       Impact factor: 5.923

10.  Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study.

Authors:  Giovanni Tarantino; Luigi Barrea; Domenico Capone; Vincenzo Citro; Teresa Mosca; Silvia Savastano
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.